Journal article
Bias in Prediction Models to Identify Patients With Colorectal Cancer at High Risk for Readmission After Resection
JCO clinical cancer informatics, v 8(8)
Oct 2024
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
PURPOSE Machine learning (ML) algorithms are used for predictive modeling in medicine, but studies often do not evaluate or report on the potential biases of the models. Our purpose was to develop clinical prediction models for readmission after surgery in patients with colorectal cancer (CRC) and to examine their potential for racial bias. METHODS We used the 2012-2020 American College of Surgeons' National Surgical Quality Improvement Program Participant Use File and Targeted Colectomy File. Patients were categorized into four race groups—White, Black or African American, other, and unknown/not reported. Potential predictive features were identified from studies of risk factors of 30-day readmission in patients with CRC. We compared four ML-based methods—logistic regression, multilayer perceptron, random forest, and XGBoost (XGB). Model bias was assessed using false-negative rate (FNR) difference, false-positive rate (FPR) difference, and disparate impact (DI). RESULTS In all, 112,077 patients were included, 67.2% of whom were White, 9.2% Black, 5.6% other race, and 18% with race not recorded. There were significant differences in the area under the receiver operating characteristics curve, FPR, and FNR between race groups across all models. Notably, patients in the other race category had higher FNR compared with Black patients in all but the XGB model, while Black patients had higher FPR than White patients in some models. Patients in the other category consistently had the lowest FPR. Applying the 80% rule for DI, the models consistently met the threshold for unfairness for the other race category. CONCLUSION Predictive models for 30-day readmission after colorectal surgery may perform unequally for different race groups, potentially propagating to inequalities in delivery of care and patient outcomes if the predictions from these models are used to direct care.
Predictive models for CRC readmission may show bias, potentially risking unequal care and outcomes.
Metrics
17 Record Views
Details
- Title
- Bias in Prediction Models to Identify Patients With Colorectal Cancer at High Risk for Readmission After Resection
- Creators
- Mary M. Lucas - Drexel UniversityMario Schootman - University of Arkansas for Medical SciencesJonathan A. Laryea - Winthrop Rockefeller FoundationSonia T. Orcutt - Winthrop Rockefeller FoundationChenghui Li - Winthrop Rockefeller FoundationJun Ying - University of Arkansas for Medical SciencesJennifer A. Rumpel - University of Arkansas for Medical SciencesChristopher C. Yang - Drexel University
- Publication Details
- JCO clinical cancer informatics, v 8(8)
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS; PHILADELPHIA
- Number of pages
- 11
- Grant note
- National Center for Advancing Translational Sciences of the National Institutes of Health: UL1TR003107 National Science Foundation: IIS-1741306, IIS-2235548 Department of Defense: W91XWH-05-1-023
Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number (UL1TR003107; M.S.). Supported, in part, by the National Science Foundation under the Grants IIS-1741306 and IIS-2235548, and by the Department of Defense under the Grant DoD W91XWH-05-1-023(C.C.Y.). This material is based upon work supported by (while serving at) the National Science Foundation.
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Information Science
- Web of Science ID
- WOS:001332592100001
- Scopus ID
- 2-s2.0-85207343851
- Other Identifier
- 991021929344404721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology